Innova Captab Ltd (INNOVACAP) is currently trading at 644.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Innova Captab Limited is an integrated pharmaceutical company in India involved in R&D, manufacturing, distribution, and marketing. The company achieved a significant milestone by commencing operations at its state-of-the-art manufacturing facility in Kathua, Jammu, enhancing capacity and operational scale. In Q2 and H1 FY26, Innova Captab reported a year-on-year revenue growth of 19.5%, highlighting strong operational execution and market demand. Exports contribute 30% to the company's total revenue, reflecting a well-diversified geographic presence that supports its growth trajectory. Despite challenges like declining API prices, the company achieved a 17% year-on-year growth in EBITDA for H1 FY26, showcasing resilience.

Over the past 52 weeks, Innova Captab Ltd has traded between a low of ₹625.00 and a high of ₹1,097.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Innova Captab Ltd has a market capitalization of approximately 3,731.35. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Innova Captab Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 29.98 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Innova Captab Ltd (INNOVACAP) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 3,731.35 Cr, Innova Captab Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Innova Captab Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Innova Captab Ltd is 29.98. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Innova Captab Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.

Key risks associated with Innova Captab Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.